Amgen Inc. (BMV:AMGN)

Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of MXN 2.98 trillion. The enterprise value is 3.88 trillion.

Market Cap	2.98T
Enterprise Value	3.88T

Important Dates

The next estimated earnings date is Tuesday, November 4, 2025.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	Aug 22, 2025

Share Statistics

Current Share Class	538.36M
Shares Outstanding	n/a
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	81.02%
Float	537.00M

Valuation Ratios

The trailing PE ratio is 23.89 and the forward PE ratio is 14.64.

PE Ratio	23.89
Forward PE	14.64
PS Ratio	4.53
PB Ratio	21.29
P/TBV Ratio	n/a
P/FCF Ratio	14.91
P/OCF Ratio	13.16
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.77, with an EV/FCF ratio of 19.38.

EV / Earnings	31.05
EV / Sales	5.98
EV / EBITDA	12.77
EV / EBIT	19.45
EV / FCF	19.38

Financial Position

The company has a current ratio of 1.31, with a Debt / Equity ratio of 7.57.

Current Ratio	1.31
Quick Ratio	0.82
Debt / Equity	7.57
Debt / EBITDA	3.44
Debt / FCF	5.30
Interest Coverage	3.11

Financial Efficiency

Return on equity (ROE) is 99.14% and return on invested capital (ROIC) is 10.15%.

Return on Equity (ROE)	99.14%
Return on Assets (ROA)	7.51%
Return on Invested Capital (ROIC)	10.15%
Return on Capital Employed (ROCE)	15.93%
Revenue Per Employee	23.52M
Profits Per Employee	4.46M
Employee Count	28,000
Asset Turnover	0.39
Inventory Turnover	1.47

Taxes

In the past 12 months, Amgen has paid 15.18 billion in taxes.

Income Tax	15.18B
Effective Tax Rate	10.84%

Stock Price Statistics

The stock price has decreased by -17.45% in the last 52 weeks. The beta is 0.48, so Amgen's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	-17.45%
50-Day Moving Average	5,408.59
200-Day Moving Average	5,124.27
Relative Strength Index (RSI)	46.49
Average Volume (20 Days)	527

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.02

Income Statement

In the last 12 months, Amgen had revenue of MXN 658.47 billion and earned 124.82 billion in profits. Earnings per share was 230.64.

Revenue	658.47B
Gross Profit	456.71B
Operating Income	202.50B
Pretax Income	140.00B
Net Income	124.82B
EBITDA	304.52B
EBIT	202.50B
Earnings Per Share (EPS)	230.64

Balance Sheet

The company has 151.39 billion in cash and 1.06 trillion in debt, giving a net cash position of -908.51 billion.

Cash & Cash Equivalents	151.39B
Total Debt	1.06T
Net Cash	-908.51B
Net Cash Per Share	n/a
Equity (Book Value)	140.08B
Book Value Per Share	260.22
Working Capital	118.01B

Cash Flow

In the last 12 months, operating cash flow was 226.54 billion and capital expenditures -26.55 billion, giving a free cash flow of 199.99 billion.

Operating Cash Flow	226.54B
Capital Expenditures	-26.55B
Free Cash Flow	199.99B
FCF Per Share	n/a

Margins

Gross margin is 69.36%, with operating and profit margins of 30.75% and 18.96%.

Gross Margin	69.36%
Operating Margin	30.75%
Pretax Margin	21.26%
Profit Margin	18.96%
EBITDA Margin	46.25%
EBIT Margin	30.75%
FCF Margin	30.37%

Dividends & Yields

This stock pays an annual dividend of 185.60, which amounts to a dividend yield of 3.50%.

Dividend Per Share	185.60
Dividend Yield	3.50%
Dividend Growth (YoY)	19.79%
Years of Dividend Growth	1
Payout Ratio	75.15%
Buyback Yield	-0.19%
Shareholder Yield	3.32%
Earnings Yield	4.19%
FCF Yield	6.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Amgen has an Altman Z-Score of 1.68 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.68
Piotroski F-Score	7